nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—ABCB1—Vismodegib—skin cancer	0.165	0.393	CbGbCtD
Amsacrine—CYP2D6—Vemurafenib—skin cancer	0.123	0.293	CbGbCtD
Amsacrine—ABCB1—Dactinomycin—skin cancer	0.0866	0.207	CbGbCtD
Amsacrine—ABCB1—Docetaxel—skin cancer	0.0447	0.107	CbGbCtD
Amsacrine—NCOA3—hair follicle—skin cancer	0.014	0.162	CbGeAlD
Amsacrine—NCOA3—nipple—skin cancer	0.00951	0.11	CbGeAlD
Amsacrine—NCOA3—neck—skin cancer	0.00941	0.108	CbGeAlD
Amsacrine—NCOA3—connective tissue—skin cancer	0.00675	0.0777	CbGeAlD
Amsacrine—TOP2A—Sorafenib—Vismodegib—skin cancer	0.00585	0.584	CbGdCrCtD
Amsacrine—TOP2A—nipple—skin cancer	0.00558	0.0643	CbGeAlD
Amsacrine—NCOA3—mammalian vulva—skin cancer	0.00556	0.064	CbGeAlD
Amsacrine—NCOA3—lymphoid tissue—skin cancer	0.00493	0.0568	CbGeAlD
Amsacrine—NCOA3—female reproductive system—skin cancer	0.00476	0.0548	CbGeAlD
Amsacrine—TOP2A—Paclitaxel—Docetaxel—skin cancer	0.00417	0.416	CbGdCrCtD
Amsacrine—NCOA3—head—skin cancer	0.00398	0.0458	CbGeAlD
Amsacrine—TOP2A—mammalian vulva—skin cancer	0.00326	0.0375	CbGeAlD
Amsacrine—KCNH2—nipple—skin cancer	0.00313	0.036	CbGeAlD
Amsacrine—NCOA3—lymph node—skin cancer	0.00278	0.032	CbGeAlD
Amsacrine—NCOA3—FOXA1 transcription factor network—SHH—skin cancer	0.002	0.0891	CbGpPWpGaD
Amsacrine—ABCB1—blood vessel—skin cancer	0.0019	0.0219	CbGeAlD
Amsacrine—NCOA3—PPARA activates gene expression—PLIN2—skin cancer	0.00175	0.0782	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT5—skin cancer	0.00173	0.0774	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.00171	0.0765	CbGpPWpGaD
Amsacrine—TOP2A—lymph node—skin cancer	0.00163	0.0188	CbGeAlD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT14—skin cancer	0.00161	0.072	CbGpPWpGaD
Amsacrine—KCNH2—female reproductive system—skin cancer	0.00156	0.018	CbGeAlD
Amsacrine—Infection—Vemurafenib—skin cancer	0.00142	0.00308	CcSEcCtD
Amsacrine—Mood swings—Temozolomide—skin cancer	0.00141	0.00305	CcSEcCtD
Amsacrine—Inflammation—Docetaxel—skin cancer	0.00141	0.00304	CcSEcCtD
Amsacrine—Lethargy—Fluorouracil—skin cancer	0.0014	0.00303	CcSEcCtD
Amsacrine—Skin disorder—Vemurafenib—skin cancer	0.00139	0.00301	CcSEcCtD
Amsacrine—Weight decreased—Bleomycin—skin cancer	0.00138	0.00299	CcSEcCtD
Amsacrine—Nausea—Vismodegib—skin cancer	0.00138	0.00298	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Docetaxel—skin cancer	0.00136	0.00295	CcSEcCtD
Amsacrine—Injection site reaction—Docetaxel—skin cancer	0.00136	0.00293	CcSEcCtD
Amsacrine—Pancytopenia—Dactinomycin—skin cancer	0.00135	0.00292	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00134	0.0029	CcSEcCtD
Amsacrine—Hypotension—Vemurafenib—skin cancer	0.00134	0.00289	CcSEcCtD
Amsacrine—Stomatitis—Bleomycin—skin cancer	0.00132	0.00287	CcSEcCtD
Amsacrine—KCNH2—head—skin cancer	0.00131	0.015	CbGeAlD
Amsacrine—Haematuria—Bleomycin—skin cancer	0.0013	0.00281	CcSEcCtD
Amsacrine—Convulsion—Imiquimod—skin cancer	0.0013	0.0028	CcSEcCtD
Amsacrine—Dysphagia—Temozolomide—skin cancer	0.00129	0.00278	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00126	0.00274	CcSEcCtD
Amsacrine—Decreased appetite—Vemurafenib—skin cancer	0.00124	0.00269	CcSEcCtD
Amsacrine—Stomatitis—Dactinomycin—skin cancer	0.00124	0.00268	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00124	0.00267	CcSEcCtD
Amsacrine—Fatigue—Vemurafenib—skin cancer	0.00123	0.00267	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—XRCC3—skin cancer	0.00123	0.0549	CbGpPWpGaD
Amsacrine—Haemoglobin—Bleomycin—skin cancer	0.00123	0.00266	CcSEcCtD
Amsacrine—Pancytopenia—Temozolomide—skin cancer	0.00122	0.00264	CcSEcCtD
Amsacrine—Haemorrhage—Bleomycin—skin cancer	0.00122	0.00264	CcSEcCtD
Amsacrine—Hypoaesthesia—Bleomycin—skin cancer	0.00121	0.00263	CcSEcCtD
Amsacrine—Infection—Imiquimod—skin cancer	0.00121	0.00262	CcSEcCtD
Amsacrine—Tachycardia—Imiquimod—skin cancer	0.00119	0.00258	CcSEcCtD
Amsacrine—Skin disorder—Imiquimod—skin cancer	0.00119	0.00257	CcSEcCtD
Amsacrine—Dysphagia—Fluorouracil—skin cancer	0.00118	0.00257	CcSEcCtD
Amsacrine—Agranulocytosis—Dactinomycin—skin cancer	0.00118	0.00256	CcSEcCtD
Amsacrine—Sepsis—Docetaxel—skin cancer	0.00118	0.00256	CcSEcCtD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.00118	0.0527	CbGpPWpGaD
Amsacrine—Weight increased—Temozolomide—skin cancer	0.00117	0.00253	CcSEcCtD
Amsacrine—Weight decreased—Temozolomide—skin cancer	0.00116	0.00252	CcSEcCtD
Amsacrine—Anorexia—Imiquimod—skin cancer	0.00116	0.00252	CcSEcCtD
Amsacrine—Phlebitis—Docetaxel—skin cancer	0.00115	0.00249	CcSEcCtD
Amsacrine—Infestation—Temozolomide—skin cancer	0.00115	0.00248	CcSEcCtD
Amsacrine—Infestation NOS—Temozolomide—skin cancer	0.00115	0.00248	CcSEcCtD
Amsacrine—Hepatitis—Dactinomycin—skin cancer	0.00114	0.00246	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00114	0.00246	CcSEcCtD
Amsacrine—Body temperature increased—Vemurafenib—skin cancer	0.00113	0.00245	CcSEcCtD
Amsacrine—Pancytopenia—Fluorouracil—skin cancer	0.00113	0.00244	CcSEcCtD
Amsacrine—Stomatitis—Temozolomide—skin cancer	0.00112	0.00242	CcSEcCtD
Amsacrine—Hepatic failure—Docetaxel—skin cancer	0.0011	0.00238	CcSEcCtD
Amsacrine—Paraesthesia—Imiquimod—skin cancer	0.0011	0.00237	CcSEcCtD
Amsacrine—Cardiac failure congestive—Docetaxel—skin cancer	0.00109	0.00236	CcSEcCtD
Amsacrine—Dyspnoea—Imiquimod—skin cancer	0.00109	0.00236	CcSEcCtD
Amsacrine—Hepatobiliary disease—Temozolomide—skin cancer	0.00108	0.00235	CcSEcCtD
Amsacrine—Alopecia—Bleomycin—skin cancer	0.00108	0.00233	CcSEcCtD
Amsacrine—Decreased appetite—Imiquimod—skin cancer	0.00106	0.0023	CcSEcCtD
Amsacrine—Infestation NOS—Fluorouracil—skin cancer	0.00106	0.00229	CcSEcCtD
Amsacrine—Infestation—Fluorouracil—skin cancer	0.00106	0.00229	CcSEcCtD
Amsacrine—Hypersensitivity—Vemurafenib—skin cancer	0.00105	0.00228	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00105	0.00228	CcSEcCtD
Amsacrine—Fatigue—Imiquimod—skin cancer	0.00105	0.00228	CcSEcCtD
Amsacrine—Atrial fibrillation—Docetaxel—skin cancer	0.00104	0.00226	CcSEcCtD
Amsacrine—Pain—Imiquimod—skin cancer	0.00104	0.00226	CcSEcCtD
Amsacrine—Haemoglobin—Temozolomide—skin cancer	0.00103	0.00224	CcSEcCtD
Amsacrine—Stomatitis—Fluorouracil—skin cancer	0.00103	0.00223	CcSEcCtD
Amsacrine—Haemorrhage—Temozolomide—skin cancer	0.00103	0.00223	CcSEcCtD
Amsacrine—Hepatitis—Temozolomide—skin cancer	0.00103	0.00223	CcSEcCtD
Amsacrine—Asthenia—Vemurafenib—skin cancer	0.00103	0.00222	CcSEcCtD
Amsacrine—Hypoaesthesia—Temozolomide—skin cancer	0.00102	0.00222	CcSEcCtD
Amsacrine—Urinary tract disorder—Temozolomide—skin cancer	0.00102	0.0022	CcSEcCtD
Amsacrine—Connective tissue disorder—Temozolomide—skin cancer	0.00101	0.00219	CcSEcCtD
Amsacrine—Lethargy—Docetaxel—skin cancer	0.00101	0.00219	CcSEcCtD
Amsacrine—Urethral disorder—Temozolomide—skin cancer	0.00101	0.00218	CcSEcCtD
Amsacrine—Alopecia—Dactinomycin—skin cancer	0.00101	0.00218	CcSEcCtD
Amsacrine—Feeling abnormal—Imiquimod—skin cancer	0.00101	0.00218	CcSEcCtD
Amsacrine—Gastrointestinal pain—Imiquimod—skin cancer	0.000998	0.00216	CcSEcCtD
Amsacrine—Agranulocytosis—Fluorouracil—skin cancer	0.000986	0.00213	CcSEcCtD
Amsacrine—Anaemia—Bleomycin—skin cancer	0.000982	0.00213	CcSEcCtD
Amsacrine—Diarrhoea—Vemurafenib—skin cancer	0.000979	0.00212	CcSEcCtD
Amsacrine—Urticaria—Imiquimod—skin cancer	0.000969	0.0021	CcSEcCtD
Amsacrine—Body temperature increased—Imiquimod—skin cancer	0.000965	0.00209	CcSEcCtD
Amsacrine—Abdominal pain—Imiquimod—skin cancer	0.000965	0.00209	CcSEcCtD
Amsacrine—Cardiac disorder—Temozolomide—skin cancer	0.000955	0.00207	CcSEcCtD
Amsacrine—CYP2D6—female reproductive system—skin cancer	0.000954	0.011	CbGeAlD
Amsacrine—Haemoglobin—Fluorouracil—skin cancer	0.000953	0.00206	CcSEcCtD
Amsacrine—Leukopenia—Bleomycin—skin cancer	0.000951	0.00206	CcSEcCtD
Amsacrine—Haemorrhage—Fluorouracil—skin cancer	0.000948	0.00205	CcSEcCtD
Amsacrine—Dizziness—Vemurafenib—skin cancer	0.000946	0.00205	CcSEcCtD
Amsacrine—Hypoaesthesia—Fluorouracil—skin cancer	0.000944	0.00204	CcSEcCtD
Amsacrine—Angiopathy—Temozolomide—skin cancer	0.000934	0.00202	CcSEcCtD
Amsacrine—Mediastinal disorder—Temozolomide—skin cancer	0.000928	0.00201	CcSEcCtD
Amsacrine—ABCB1—epithelium—skin cancer	0.000924	0.0106	CbGeAlD
Amsacrine—Anaemia—Dactinomycin—skin cancer	0.000916	0.00198	CcSEcCtD
Amsacrine—KCNH2—lymph node—skin cancer	0.000915	0.0105	CbGeAlD
Amsacrine—Vomiting—Vemurafenib—skin cancer	0.00091	0.00197	CcSEcCtD
Amsacrine—Alopecia—Temozolomide—skin cancer	0.00091	0.00197	CcSEcCtD
Amsacrine—Rash—Vemurafenib—skin cancer	0.000902	0.00195	CcSEcCtD
Amsacrine—Mental disorder—Temozolomide—skin cancer	0.000902	0.00195	CcSEcCtD
Amsacrine—Dermatitis—Vemurafenib—skin cancer	0.000901	0.00195	CcSEcCtD
Amsacrine—Hypersensitivity—Imiquimod—skin cancer	0.000899	0.00195	CcSEcCtD
Amsacrine—Headache—Vemurafenib—skin cancer	0.000896	0.00194	CcSEcCtD
Amsacrine—Malnutrition—Temozolomide—skin cancer	0.000896	0.00194	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000891	0.00193	CcSEcCtD
Amsacrine—Leukopenia—Dactinomycin—skin cancer	0.000887	0.00192	CcSEcCtD
Amsacrine—Asthenia—Imiquimod—skin cancer	0.000876	0.0019	CcSEcCtD
Amsacrine—Confusional state—Bleomycin—skin cancer	0.000874	0.00189	CcSEcCtD
Amsacrine—Infection—Bleomycin—skin cancer	0.000861	0.00186	CcSEcCtD
Amsacrine—Dysphagia—Docetaxel—skin cancer	0.000855	0.00185	CcSEcCtD
Amsacrine—Nausea—Vemurafenib—skin cancer	0.00085	0.00184	CcSEcCtD
Amsacrine—Thrombocytopenia—Bleomycin—skin cancer	0.000849	0.00184	CcSEcCtD
Amsacrine—Arrhythmia—Fluorouracil—skin cancer	0.000847	0.00183	CcSEcCtD
Amsacrine—Vision blurred—Temozolomide—skin cancer	0.000844	0.00183	CcSEcCtD
Amsacrine—Alopecia—Fluorouracil—skin cancer	0.000838	0.00181	CcSEcCtD
Amsacrine—Diarrhoea—Imiquimod—skin cancer	0.000835	0.00181	CcSEcCtD
Amsacrine—Anaemia—Temozolomide—skin cancer	0.000828	0.00179	CcSEcCtD
Amsacrine—Anorexia—Bleomycin—skin cancer	0.000826	0.00179	CcSEcCtD
Amsacrine—Pancytopenia—Docetaxel—skin cancer	0.000812	0.00176	CcSEcCtD
Amsacrine—Hypotension—Bleomycin—skin cancer	0.00081	0.00175	CcSEcCtD
Amsacrine—Dizziness—Imiquimod—skin cancer	0.000807	0.00175	CcSEcCtD
Amsacrine—Infection—Dactinomycin—skin cancer	0.000803	0.00174	CcSEcCtD
Amsacrine—Leukopenia—Temozolomide—skin cancer	0.000802	0.00174	CcSEcCtD
Amsacrine—ABCB1—mammalian vulva—skin cancer	0.000801	0.00923	CbGeAlD
Amsacrine—CYP2D6—head—skin cancer	0.000797	0.00918	CbGeAlD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MSH2—skin cancer	0.000792	0.0354	CbGpPWpGaD
Amsacrine—Thrombocytopenia—Dactinomycin—skin cancer	0.000792	0.00171	CcSEcCtD
Amsacrine—Paraesthesia—Bleomycin—skin cancer	0.000778	0.00169	CcSEcCtD
Amsacrine—Weight increased—Docetaxel—skin cancer	0.000778	0.00168	CcSEcCtD
Amsacrine—Vision blurred—Fluorouracil—skin cancer	0.000778	0.00168	CcSEcCtD
Amsacrine—Convulsion—Temozolomide—skin cancer	0.000776	0.00168	CcSEcCtD
Amsacrine—Vomiting—Imiquimod—skin cancer	0.000776	0.00168	CcSEcCtD
Amsacrine—Weight decreased—Docetaxel—skin cancer	0.000774	0.00168	CcSEcCtD
Amsacrine—Dyspnoea—Bleomycin—skin cancer	0.000773	0.00167	CcSEcCtD
Amsacrine—Anorexia—Dactinomycin—skin cancer	0.000771	0.00167	CcSEcCtD
Amsacrine—Rash—Imiquimod—skin cancer	0.000769	0.00167	CcSEcCtD
Amsacrine—Dermatitis—Imiquimod—skin cancer	0.000769	0.00166	CcSEcCtD
Amsacrine—Headache—Imiquimod—skin cancer	0.000764	0.00166	CcSEcCtD
Amsacrine—Anaemia—Fluorouracil—skin cancer	0.000763	0.00165	CcSEcCtD
Amsacrine—Infestation NOS—Docetaxel—skin cancer	0.000762	0.00165	CcSEcCtD
Amsacrine—Infestation—Docetaxel—skin cancer	0.000762	0.00165	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000758	0.00164	CcSEcCtD
Amsacrine—Decreased appetite—Bleomycin—skin cancer	0.000754	0.00163	CcSEcCtD
Amsacrine—Renal failure—Docetaxel—skin cancer	0.00075	0.00162	CcSEcCtD
Amsacrine—Stomatitis—Docetaxel—skin cancer	0.000743	0.00161	CcSEcCtD
Amsacrine—Jaundice—Docetaxel—skin cancer	0.000743	0.00161	CcSEcCtD
Amsacrine—Pain—Bleomycin—skin cancer	0.000741	0.00161	CcSEcCtD
Amsacrine—Leukopenia—Fluorouracil—skin cancer	0.000739	0.0016	CcSEcCtD
Amsacrine—Confusional state—Temozolomide—skin cancer	0.000737	0.0016	CcSEcCtD
Amsacrine—Infection—Temozolomide—skin cancer	0.000726	0.00157	CcSEcCtD
Amsacrine—Nausea—Imiquimod—skin cancer	0.000725	0.00157	CcSEcCtD
Amsacrine—Hepatobiliary disease—Docetaxel—skin cancer	0.000721	0.00156	CcSEcCtD
Amsacrine—Thrombocytopenia—Temozolomide—skin cancer	0.000716	0.00155	CcSEcCtD
Amsacrine—Convulsion—Fluorouracil—skin cancer	0.000715	0.00155	CcSEcCtD
Amsacrine—Feeling abnormal—Bleomycin—skin cancer	0.000714	0.00155	CcSEcCtD
Amsacrine—Agranulocytosis—Docetaxel—skin cancer	0.000712	0.00154	CcSEcCtD
Amsacrine—ABCB1—lymphoid tissue—skin cancer	0.000712	0.00819	CbGeAlD
Amsacrine—Skin disorder—Temozolomide—skin cancer	0.00071	0.00154	CcSEcCtD
Amsacrine—Decreased appetite—Dactinomycin—skin cancer	0.000703	0.00152	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—RASA1—skin cancer	0.0007	0.0312	CbGpPWpGaD
Amsacrine—Fatigue—Dactinomycin—skin cancer	0.000697	0.00151	CcSEcCtD
Amsacrine—Anorexia—Temozolomide—skin cancer	0.000697	0.00151	CcSEcCtD
Amsacrine—Pain—Dactinomycin—skin cancer	0.000691	0.0015	CcSEcCtD
Amsacrine—Urticaria—Bleomycin—skin cancer	0.000689	0.00149	CcSEcCtD
Amsacrine—Haemoglobin—Docetaxel—skin cancer	0.000688	0.00149	CcSEcCtD
Amsacrine—ABCB1—female reproductive system—skin cancer	0.000686	0.0079	CbGeAlD
Amsacrine—Body temperature increased—Bleomycin—skin cancer	0.000685	0.00148	CcSEcCtD
Amsacrine—Haemorrhage—Docetaxel—skin cancer	0.000685	0.00148	CcSEcCtD
Amsacrine—Hepatitis—Docetaxel—skin cancer	0.000685	0.00148	CcSEcCtD
Amsacrine—Hypoaesthesia—Docetaxel—skin cancer	0.000681	0.00147	CcSEcCtD
Amsacrine—Confusional state—Fluorouracil—skin cancer	0.000679	0.00147	CcSEcCtD
Amsacrine—Urinary tract disorder—Docetaxel—skin cancer	0.000676	0.00146	CcSEcCtD
Amsacrine—Connective tissue disorder—Docetaxel—skin cancer	0.000673	0.00146	CcSEcCtD
Amsacrine—Urethral disorder—Docetaxel—skin cancer	0.000671	0.00145	CcSEcCtD
Amsacrine—Infection—Fluorouracil—skin cancer	0.000669	0.00145	CcSEcCtD
Amsacrine—Feeling abnormal—Dactinomycin—skin cancer	0.000666	0.00144	CcSEcCtD
Amsacrine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000661	0.00143	CcSEcCtD
Amsacrine—Thrombocytopenia—Fluorouracil—skin cancer	0.00066	0.00143	CcSEcCtD
Amsacrine—Tachycardia—Fluorouracil—skin cancer	0.000658	0.00142	CcSEcCtD
Amsacrine—Paraesthesia—Temozolomide—skin cancer	0.000657	0.00142	CcSEcCtD
Amsacrine—Dyspnoea—Temozolomide—skin cancer	0.000652	0.00141	CcSEcCtD
Amsacrine—Anorexia—Fluorouracil—skin cancer	0.000642	0.00139	CcSEcCtD
Amsacrine—Abdominal pain—Dactinomycin—skin cancer	0.000639	0.00138	CcSEcCtD
Amsacrine—Body temperature increased—Dactinomycin—skin cancer	0.000639	0.00138	CcSEcCtD
Amsacrine—Hypersensitivity—Bleomycin—skin cancer	0.000639	0.00138	CcSEcCtD
Amsacrine—Decreased appetite—Temozolomide—skin cancer	0.000636	0.00138	CcSEcCtD
Amsacrine—Cardiac disorder—Docetaxel—skin cancer	0.000635	0.00138	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000631	0.00137	CcSEcCtD
Amsacrine—Fatigue—Temozolomide—skin cancer	0.00063	0.00136	CcSEcCtD
Amsacrine—Hypotension—Fluorouracil—skin cancer	0.00063	0.00136	CcSEcCtD
Amsacrine—Pain—Temozolomide—skin cancer	0.000625	0.00135	CcSEcCtD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—CDK4—skin cancer	0.000622	0.0278	CbGpPWpGaD
Amsacrine—Asthenia—Bleomycin—skin cancer	0.000622	0.00135	CcSEcCtD
Amsacrine—Angiopathy—Docetaxel—skin cancer	0.000621	0.00134	CcSEcCtD
Amsacrine—Mediastinal disorder—Docetaxel—skin cancer	0.000617	0.00134	CcSEcCtD
Amsacrine—Arrhythmia—Docetaxel—skin cancer	0.000611	0.00132	CcSEcCtD
Amsacrine—Paraesthesia—Fluorouracil—skin cancer	0.000605	0.00131	CcSEcCtD
Amsacrine—Alopecia—Docetaxel—skin cancer	0.000605	0.00131	CcSEcCtD
Amsacrine—Feeling abnormal—Temozolomide—skin cancer	0.000603	0.0013	CcSEcCtD
Amsacrine—Dyspnoea—Fluorouracil—skin cancer	0.000601	0.0013	CcSEcCtD
Amsacrine—Mental disorder—Docetaxel—skin cancer	0.0006	0.0013	CcSEcCtD
Amsacrine—Gastrointestinal pain—Temozolomide—skin cancer	0.000598	0.00129	CcSEcCtD
Amsacrine—Malnutrition—Docetaxel—skin cancer	0.000596	0.00129	CcSEcCtD
Amsacrine—Hypersensitivity—Dactinomycin—skin cancer	0.000596	0.00129	CcSEcCtD
Amsacrine—Decreased appetite—Fluorouracil—skin cancer	0.000586	0.00127	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000582	0.00126	CcSEcCtD
Amsacrine—Urticaria—Temozolomide—skin cancer	0.000581	0.00126	CcSEcCtD
Amsacrine—Asthenia—Dactinomycin—skin cancer	0.00058	0.00126	CcSEcCtD
Amsacrine—Abdominal pain—Temozolomide—skin cancer	0.000578	0.00125	CcSEcCtD
Amsacrine—Body temperature increased—Temozolomide—skin cancer	0.000578	0.00125	CcSEcCtD
Amsacrine—Pain—Fluorouracil—skin cancer	0.000576	0.00125	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—FOXO4—skin cancer	0.000574	0.0256	CbGpPWpGaD
Amsacrine—ABCB1—head—skin cancer	0.000573	0.0066	CbGeAlD
Amsacrine—Feeling abnormal—Fluorouracil—skin cancer	0.000555	0.0012	CcSEcCtD
Amsacrine—Diarrhoea—Dactinomycin—skin cancer	0.000553	0.0012	CcSEcCtD
Amsacrine—Vomiting—Bleomycin—skin cancer	0.000551	0.00119	CcSEcCtD
Amsacrine—Anaemia—Docetaxel—skin cancer	0.000551	0.00119	CcSEcCtD
Amsacrine—Rash—Bleomycin—skin cancer	0.000547	0.00118	CcSEcCtD
Amsacrine—Dermatitis—Bleomycin—skin cancer	0.000546	0.00118	CcSEcCtD
Amsacrine—Hypersensitivity—Temozolomide—skin cancer	0.000539	0.00117	CcSEcCtD
Amsacrine—Urticaria—Fluorouracil—skin cancer	0.000535	0.00116	CcSEcCtD
Amsacrine—Leukopenia—Docetaxel—skin cancer	0.000533	0.00115	CcSEcCtD
Amsacrine—Body temperature increased—Fluorouracil—skin cancer	0.000533	0.00115	CcSEcCtD
Amsacrine—Asthenia—Temozolomide—skin cancer	0.000525	0.00114	CcSEcCtD
Amsacrine—Convulsion—Docetaxel—skin cancer	0.000516	0.00112	CcSEcCtD
Amsacrine—Nausea—Bleomycin—skin cancer	0.000515	0.00111	CcSEcCtD
Amsacrine—Vomiting—Dactinomycin—skin cancer	0.000514	0.00111	CcSEcCtD
Amsacrine—Rash—Dactinomycin—skin cancer	0.00051	0.0011	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000504	0.00109	CcSEcCtD
Amsacrine—Diarrhoea—Temozolomide—skin cancer	0.0005	0.00108	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—SCN10A—skin cancer	0.000499	0.0223	CbGpPWpGaD
Amsacrine—Hypersensitivity—Fluorouracil—skin cancer	0.000496	0.00107	CcSEcCtD
Amsacrine—Confusional state—Docetaxel—skin cancer	0.00049	0.00106	CcSEcCtD
Amsacrine—Dizziness—Temozolomide—skin cancer	0.000484	0.00105	CcSEcCtD
Amsacrine—Infection—Docetaxel—skin cancer	0.000483	0.00105	CcSEcCtD
Amsacrine—Nausea—Dactinomycin—skin cancer	0.00048	0.00104	CcSEcCtD
Amsacrine—Thrombocytopenia—Docetaxel—skin cancer	0.000476	0.00103	CcSEcCtD
Amsacrine—Tachycardia—Docetaxel—skin cancer	0.000475	0.00103	CcSEcCtD
Amsacrine—Skin disorder—Docetaxel—skin cancer	0.000472	0.00102	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00047	0.021	CbGpPWpGaD
Amsacrine—Vomiting—Temozolomide—skin cancer	0.000465	0.00101	CcSEcCtD
Amsacrine—Anorexia—Docetaxel—skin cancer	0.000464	0.001	CcSEcCtD
Amsacrine—Rash—Temozolomide—skin cancer	0.000461	0.000998	CcSEcCtD
Amsacrine—Diarrhoea—Fluorouracil—skin cancer	0.000461	0.000998	CcSEcCtD
Amsacrine—Dermatitis—Temozolomide—skin cancer	0.000461	0.000997	CcSEcCtD
Amsacrine—Headache—Temozolomide—skin cancer	0.000458	0.000992	CcSEcCtD
Amsacrine—Hypotension—Docetaxel—skin cancer	0.000454	0.000984	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—NKX2-1—skin cancer	0.000449	0.0201	CbGpPWpGaD
Amsacrine—Dizziness—Fluorouracil—skin cancer	0.000446	0.000965	CcSEcCtD
Amsacrine—Paraesthesia—Docetaxel—skin cancer	0.000437	0.000945	CcSEcCtD
Amsacrine—Nausea—Temozolomide—skin cancer	0.000434	0.00094	CcSEcCtD
Amsacrine—Dyspnoea—Docetaxel—skin cancer	0.000434	0.000939	CcSEcCtD
Amsacrine—Vomiting—Fluorouracil—skin cancer	0.000428	0.000927	CcSEcCtD
Amsacrine—Rash—Fluorouracil—skin cancer	0.000425	0.00092	CcSEcCtD
Amsacrine—Dermatitis—Fluorouracil—skin cancer	0.000424	0.000919	CcSEcCtD
Amsacrine—Decreased appetite—Docetaxel—skin cancer	0.000423	0.000915	CcSEcCtD
Amsacrine—Headache—Fluorouracil—skin cancer	0.000422	0.000914	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00042	0.000909	CcSEcCtD
Amsacrine—Fatigue—Docetaxel—skin cancer	0.000419	0.000908	CcSEcCtD
Amsacrine—Pain—Docetaxel—skin cancer	0.000416	0.0009	CcSEcCtD
Amsacrine—ABCB1—lymph node—skin cancer	0.000401	0.00462	CbGeAlD
Amsacrine—Feeling abnormal—Docetaxel—skin cancer	0.000401	0.000868	CcSEcCtD
Amsacrine—Nausea—Fluorouracil—skin cancer	0.0004	0.000866	CcSEcCtD
Amsacrine—Gastrointestinal pain—Docetaxel—skin cancer	0.000398	0.000861	CcSEcCtD
Amsacrine—Abdominal pain—Docetaxel—skin cancer	0.000384	0.000832	CcSEcCtD
Amsacrine—Body temperature increased—Docetaxel—skin cancer	0.000384	0.000832	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000381	0.017	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CDK4—skin cancer	0.000363	0.0162	CbGpPWpGaD
Amsacrine—Hypersensitivity—Docetaxel—skin cancer	0.000358	0.000776	CcSEcCtD
Amsacrine—Asthenia—Docetaxel—skin cancer	0.000349	0.000755	CcSEcCtD
Amsacrine—Diarrhoea—Docetaxel—skin cancer	0.000333	0.00072	CcSEcCtD
Amsacrine—Dizziness—Docetaxel—skin cancer	0.000322	0.000696	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—BRAF—skin cancer	0.000321	0.0143	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—skin cancer	0.000309	0.0138	CbGpPWpGaD
Amsacrine—Vomiting—Docetaxel—skin cancer	0.000309	0.000669	CcSEcCtD
Amsacrine—Rash—Docetaxel—skin cancer	0.000307	0.000664	CcSEcCtD
Amsacrine—Dermatitis—Docetaxel—skin cancer	0.000306	0.000663	CcSEcCtD
Amsacrine—Headache—Docetaxel—skin cancer	0.000305	0.00066	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—BRAF—skin cancer	0.000304	0.0135	CbGpPWpGaD
Amsacrine—Nausea—Docetaxel—skin cancer	0.000289	0.000625	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—RASA1—skin cancer	0.000287	0.0128	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000271	0.0121	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000257	0.0114	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—skin cancer	0.000247	0.011	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—TP53—skin cancer	0.00024	0.0107	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PLIN2—skin cancer	0.000209	0.00935	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDK4—skin cancer	0.000174	0.00777	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.000174	0.00775	CbGpPWpGaD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—skin cancer	0.000173	0.00773	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CSPG4—skin cancer	0.000169	0.00754	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—KRAS—skin cancer	0.000164	0.00733	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000154	0.00689	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CDK4—skin cancer	0.000141	0.00628	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—HRAS—skin cancer	0.00014	0.00623	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN2A—skin cancer	0.000133	0.00594	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000132	0.00588	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—CDK4—skin cancer	0.000127	0.00565	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ENO2—skin cancer	0.000115	0.00512	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	0.000114	0.00507	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MLH1—skin cancer	0.000112	0.00501	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—skin cancer	0.000105	0.0047	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	9.43e-05	0.00421	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.98e-05	0.00401	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	8.91e-05	0.00398	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	8.45e-05	0.00377	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—BRAF—skin cancer	8.32e-05	0.00371	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NRAS—skin cancer	7.82e-05	0.00349	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—KRAS—skin cancer	6.73e-05	0.003	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ERCC2—skin cancer	6.67e-05	0.00298	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDK4—skin cancer	6.38e-05	0.00285	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TERT—skin cancer	6.38e-05	0.00285	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	6.31e-05	0.00282	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	6.12e-05	0.00273	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—skin cancer	5.83e-05	0.0026	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HRAS—skin cancer	5.72e-05	0.00255	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDK4—skin cancer	5.71e-05	0.00255	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	5.61e-05	0.0025	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IL6—skin cancer	5.48e-05	0.00244	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—skin cancer	5.39e-05	0.0024	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—skin cancer	4.93e-05	0.0022	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—skin cancer	4.88e-05	0.00218	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—skin cancer	4.36e-05	0.00195	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	4.34e-05	0.00194	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—skin cancer	4e-05	0.00178	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—skin cancer	3.83e-05	0.00171	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	3.1e-05	0.00138	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLIN2—skin cancer	3.02e-05	0.00135	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLIN2—skin cancer	2.85e-05	0.00127	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CSPG4—skin cancer	2.44e-05	0.00109	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—skin cancer	2.43e-05	0.00108	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CSPG4—skin cancer	2.3e-05	0.00103	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.08e-05	0.000927	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.85e-05	0.000824	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO2—skin cancer	1.66e-05	0.000739	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO2—skin cancer	1.56e-05	0.000697	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ERCC2—skin cancer	9.63e-06	0.00043	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ERCC2—skin cancer	9.07e-06	0.000405	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—skin cancer	5.77e-06	0.000258	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—skin cancer	5.44e-06	0.000243	CbGpPWpGaD
